Streetbeat News

Products Services

BNTX

PFE

BioNTech SE (BNTX) reported a significant drop in revenue and earnings for the fourth quarter, as it shifts focus from COVID-19 vaccines to cancer drug development. Despite a 90% YoY drop in net income for 2023, BioNTech remains optimistic about its oncology pipeline, expecting revenue growth in 2025 and its first oncology launch in 2026. Pfizer Inc (PFE), BioNTech's partner in COVID-19 vaccine development, also reported a 54% decline in vaccine sales and is turning towards oncology.

Portfolio Pulse from Upwallstreet

March 20, 2024 | 5:38 pm

JBL

OpenLight has announced a partnership with Jabil (JBL) to meet the growing demand for optical components in AI, ML, and datacenter applications. This collaboration introduces an industry-first 'Silicon to Solutions' manufacturing approach, aimed at scaling the production of current and next-generation Photonic Integrated Circuits (PICs).

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 5:31 pm

AMD

NVDA

At Nvidia's GTC conference, multiple product and partnership announcements were made, including the new GPU architecture, Blackwell. Analysts see Nvidia's AI initiatives as a significant growth driver, with a potential market of ~$100 trillion. Price targets for Nvidia (NVDA) have been raised by several analysts, citing its competitive positioning against AMD in the AI and accelerated computing markets. Nvidia's pricing strategy for Blackwell is seen as a challenge for AMD, with expectations of maintaining high gross margins and leading the AI industry.

Portfolio Pulse from Anusuya Lahiri

March 20, 2024 | 5:29 pm

VANI

At Benzinga's Healthcare Summit, Vivani Medical's Co-Founder & CEO, Adam Mendelsohn, mentioned that the company is not yet in clinical trials but hopes to start them soon.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 5:26 pm

IGC

OTSKF

OTSKY

IGC Pharma Inc (NYSE:IGC) announced positive interim Phase 2 trial results for IGC-AD1, showing significant reduction in Alzheimer's Disease agitation compared to placebo. The trial used the Cohen Mansfield Agitation Inventory for assessment, with notable improvements as early as week two. In contrast, Otsuka Holding Co Ltd's (OTC:OTSKY) (OTC:OTSKF) Rexulti received FDA approval with less pronounced effects in a similar context. IGC's stock dropped 13.80% to $0.33 following the announcement.

Portfolio Pulse from Vandana Singh

March 20, 2024 | 5:21 pm

VANI

At Benzinga's Healthcare Summit, Vivani Medical's Co-Founder & CEO, Adam Mendelsohn, discussed the company's development of a weight loss drug designed to prevent weight regain after discontinuation. This addresses a common issue with existing weight loss medications, where patients often regain weight quickly once they stop taking the drugs.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 5:14 pm

AMZN

EBAY

WMT

A study by CBD Oracle revealed that 'hemp gummies' sold on Amazon, Walmart, and eBay contain illegal levels of delta-8 THC, violating federal regulations. The research, which tested 56 products from Amazon, found 30% contained undeclared CBD and 43% had no hemp ingredients. Three products had dangerously high delta-8 THC levels. The report calls for action from these platforms to address misleading marketing and product safety.

Portfolio Pulse from Patricio Liddle

March 20, 2024 | 5:13 pm

VANI

At Benzinga's Healthcare Summit, Vivani Medical's Co-Founder & CEO, Adam Mendelsohn, started participating in interviews, indicating a potential spotlight on the company.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 5:11 pm

EZFL

EzFill announced it will start providing mobile fuel services to Millwork Sales and Batesville, expecting to add 175,000 gallons per year and approximately $752,000 in annual revenues.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 5:10 pm

VRNOF

Verano Holdings Corp. (OTCQX:VRNOF) has launched the Cabbage Club, a national cannabis membership program, initially available in its 13 Zen Leaf dispensaries in New Jersey and Illinois, with plans to expand across its 138 dispensaries in 13 states. The club offers various membership levels with benefits including store credits, coupons, exclusive merchandise, and VIP event access. Verano's shares were down 1.70% at $5.21 per share following the announcement.

Portfolio Pulse from Jelena Martinovic

March 20, 2024 | 5:04 pm